MARKET

ATHX

ATHX

Athersys Inc
NASDAQ
0.4289
-0.0032
-0.74%
Opening 11:18 10/02 EDT
OPEN
0.4352
PREV CLOSE
0.4321
HIGH
0.4352
LOW
0.4040
VOLUME
133.87K
TURNOVER
0
52 WEEK HIGH
2.760
52 WEEK LOW
0.2560
MARKET CAP
11.46M
P/E (TTM)
-0.1416
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ATHX last week (0925-0929)?
Weekly Report · 13h ago
Athersys Inc: Prospectus [Rule 424(b)(3)]
Press release · 6d ago
Weekly Report: what happened at ATHX last week (0918-0922)?
Weekly Report · 09/25 10:41
Athersys Inc: Notice of Effectiveness
Press release · 09/23 16:15
Athersys Inc: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 09/19 11:05
Weekly Report: what happened at ATHX last week (0911-0915)?
Weekly Report · 09/18 10:36
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/15 21:31
Athersys Inc: Initial statement of beneficial ownership of securities
Press release · 09/14 15:04
More
About ATHX
Athersys, Inc. is a biotechnology company focused primarily on the field of regenerative medicine. The Company is engaged in the discovery and development of therapeutic product candidates to address unmet medical needs in multiple disease areas. Its MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product and is in late-stage clinical development. MultiStem cell therapy includes treatment of critical care indications, neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease, and other conditions. MultiStem cell therapy is manufactured from human stem cells obtained from adult bone marrow and these cells are alternatively obtained from other tissue sources. It is conducting a Phase III clinical trial of MultiStem cell therapy for the treatment of ischemic stroke, referred to as MultiStem Administration for Stroke Treatment and Enhanced Recovery Study-2 (MASTERS-2).

Webull offers kinds of Athersys Inc stock information, including NASDAQ:ATHX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATHX stock methods without spending real money on the virtual paper trading platform.